Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in refractory partial epilepsy
NCT00236860Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- May 1989
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in partial epilepsy comparing Topiramate with Placebo (2 arms). Primary endpoint: Percent reduction in the average monthly seizure rate. Started May 1989; status: completed.
02
Drugs
topiramate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00236860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236860.